000 02388nam a22003855i 4500
999 _c392072
_d392072
001 392072
003 ES-MaUEC
005 20231117111838.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 120905s2012 xxu| o |||| 0|eng d
020 _a9781627030083
024 7 _a10.1007/978-1-62703-008-3
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRS420
_b2012 EB
245 0 0 _aRational Drug Design :
_bMethods and Protocols
_cedited by Yi Zheng
250 _a1st edition 2012
264 1 _aTotowa, NJ
_bHumana Press
_c2012
300 _a1 recurso en línea (XI, 230 páginas)
_b58 ilustraciones, 22 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v928
520 _aOver the past  three decades there have been new developments in therapeutic drug design. In Rational Drug Design: Methods and Protocols,  expert researchers in the field detail many of the methodologies used to study rational drug design. These include methods such as virtual screening of chemical hits, rational lead discovery by high throughput screening, combinatorial and fragment based lead generation, peptide based drug discovery, and animal models of lead validation. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls.   Authoritative and practical, Rational Drug Design: Methods and Protocols seeks to aid scientists in the further study of rational drug design and future drug discovery.
988 _aSpringer_Protocols_2012
650 7 _2embne
_9139235
_aDrogas
776 0 8 _iPrinted edition:
_z9781627030076
776 0 8 _iPrinted edition:
_z9781627030090
776 0 8 _iPrinted edition:
_z9781493959006
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-62703-008-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b11/2023
_dz
_eIG
_zSI